BHV-7000 Responsive Neurostimulation System (RNS) Study (NCT07125261)
BHV-7000 Efficacy Against Epileptiform Activity in Patients With Epilepsy Implanted With RNS
🩺 Plain-English Summary (8th-Grade Level)
This is an open label study to assess the biological effect of BHV-7000 on abnormal activity recorded by the RNS System in patients with focal epilepsy implanted with the RNS System. BHV-7000 is a potassium channel activator being evaluated for use in epilepsy. Participants are offered the drug for 4 weeks. Activity during that treatment period is compared to a 90-day retrospective baseline period in which other medications and device settings were stable, and also to a 4-week withdrawal period after treatment is discontinued. The study is open to patients with RNS regardless of whether they report clinical seizures, as long as the device recordings continue to show epileptiform activity.
Who can join: Review the eligibility criteria below.
Location: Yale Comprehensive Epilepsy Center — New Haven, Connecticut
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Yale Comprehensive Epilepsy Center — New Haven, Connecticut
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Epilepsy
- Neural Circulatory Control and SUDEP Risk. — Rochester, Minnesota
- RESEARCH EVALUATING VAGAL EXCITATION AND ANATOMICAL LINKS — Stanford, California
- Acute Recording of Stereotyped High-Frequency Oscillations — Rochester, Minnesota
- Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy — Rochester, Minnesota
- Acoustic Stimulation for Seizure Suppression — New York, New York
Explore by condition: All Epilepsy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.